ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1649

B Cell Subset Contribution to Autoantibodies in Lupus

Kristina Ottens1, Jalyn Schneider1 and Anne Satterthwaite2, 1UT Southwestern Medical Center, Dallas, 2UT Southwestern Medical Center, Dallas, TX

Meeting: ACR Convergence 2024

Keywords: Autoantibody(ies), B-Lymphocyte, Systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 17, 2024

Title: Abstracts: B Cell Biology & Targets in Autoimmune & Inflammatory Disease II

Session Type: Abstract Session

Session Time: 1:00PM-2:30PM

Background/Purpose: Systemic lupus erythematous is characterized by the production of pathogenic autoantibodies that drive inflammation and tissue damage.  Defining the B cell subsets that give rise to these autoantibodies may reveal therapeutic strategies that target pathogenic B cells while sparing responses to immunization and infection.  T-bet+ B cells are thought to be pathogenic in lupus, while B-1 B cells have been suggested to play both protective and pathogenic roles, depending on the study.  Both subsets have been implicated in the Lyn-deficient mouse model of lupus.  We sought to identify the specificity of plasma cells (PCs) generated by T-bet+ B cells and B-1 cells in Lyn-/- mice.    

Methods: To identify PCs derived from particular B cell subsets we used a cre-inducible tomato reporter that labels cells that express cre and their progeny.  We used Tbx21-cre to induce the reporter in T-bet+ B cells, and Ighg3-cre to label B-1 cells and their progeny.  Reporter expressing PCs and their unlabeled counterparts were sorted from the spleens of Tbx21-cre.tomato.Lyn-/- and Ighg3-cre.tomato.Lyn-/- mice and cultured overnight.  Supernatants were analyzed for autoreactivity by autoantigen array. 

Results: PCs derived from T-bet+ B cells were a dominant source of many IgG autoantibodies, including those targeting DNA and RNA containing antigens.  In contrast, IgG produced by Ighg3-labeled PCs was consistently under-enriched in several of these specificities, including ssDNA, dsDNA, genomic DNA, SmD1, and TIF1 gamma.  IgM autoantibodies were generally more evenly distributed among B cell subsets, but T-bet+ B cell derived PCs were particularly enriched in IgM against RNA containing antigens. 

Conclusion: T-bet+ B cells are more important than B-1 cells for the production of many IgG autoantibodies in the Lyn-/- lupus model.  Ongoing studies will determine whether B-1 cells play other protective or pathogenic roles in autoimmune disease. 


Disclosures: K. Ottens: None; J. Schneider: None; A. Satterthwaite: Amgen, 11.

To cite this abstract in AMA style:

Ottens K, Schneider J, Satterthwaite A. B Cell Subset Contribution to Autoantibodies in Lupus [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/b-cell-subset-contribution-to-autoantibodies-in-lupus/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/b-cell-subset-contribution-to-autoantibodies-in-lupus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology